Compare TR & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TR | TXG |
|---|---|---|
| Founded | 1896 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Foods | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Staples | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.8B |
| IPO Year | N/A | 2019 |
| Metric | TR | TXG |
|---|---|---|
| Price | $41.51 | $18.88 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 14 |
| Target Price | N/A | ★ $16.39 |
| AVG Volume (30 Days) | 101.7K | ★ 2.5M |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | ★ 0.87% | N/A |
| EPS Growth | N/A | ★ 76.97 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $245,893,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $7.32 |
| P/E Ratio | $32.36 | ★ N/A |
| Revenue Growth | N/A | ★ 68.06 |
| 52 Week Low | $29.13 | $6.78 |
| 52 Week High | $44.27 | $23.56 |
| Indicator | TR | TXG |
|---|---|---|
| Relative Strength Index (RSI) | 69.44 | 51.38 |
| Support Level | $40.92 | $17.26 |
| Resistance Level | $41.92 | $19.78 |
| Average True Range (ATR) | 1.07 | 1.31 |
| MACD | 0.23 | -0.07 |
| Stochastic Oscillator | 69.17 | 61.02 |
Tootsie Roll Industries Inc manufactures and sells confectionery products. Notable varieties include Tootsie Roll and Tootsie Pops, Charms, Blow-Pops, Dots, Junior Mints, Sugar Daddy and Sugar Babies, Andes, Dubble Bubble, Razzles among others. The company sells its products to wholesale distributors and directly to retail stores. Geographically, it generates a majority of its revenue from the United States and rest from Canada, Mexico and other regions.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).